There is increasing focus on understanding the nature of chronic obstructive pulmonary
disease (COPD) during the earlier stages. Mild COPD (Global Initiative for Chronic …

COPD is progressive and typically begins many years before a definite diagnosis is made.
As the rate of decline in lung function may be faster in the initial stages of the disease, early …

Chronic obstructive pulmonary disease (COPD) is a common and often progressive
inflammatory disease of the airways that is both preventable and treatable. It is well …

Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality
worldwide. It is well established that patients with mild to moderate disease represent the …

Chronic obstructive pulmonary disease (COPD) affects more than 24 million individuals in
the United States, although at least half of the cases are not diagnosed. Proactive diagnosis …

Aims Chronic obstructive pulmonary disease (COPD) is usually a progressive condition.
Undiagnosed early‐stage disease, particularly in symptomatic patients, is likely to become …

Early stage COPD carries a significant healthcare burden that is currently underrecognised,
underdiagnosed and undertreated. Furthermore, patients at this stage can rapidly decline to …

Chronic obstructive pulmonary disease (COPD) is a leading cause of disability and mortality.
Caring for patients with COPD, particularly those with advanced disease who experience …

Chronic obstructive pulmonary disease (COPD) is a major health problem worldwide and
most of those afflicted have mild to moderate disease as measured by spirometry. There is …

Introduction: Treatment recommendations are based on randomized controlled trials (RCTs).
However, only about 1 in 20 people meet the inclusion criteria for RCTs forming consensus …